Literature DB >> 24191859

Reprogramming adipose tissue-derived mesenchymal stem cells into pluripotent stem cells by a mutant adeno-associated viral vector.

Mong-Jen Chen1, Yuanqing Lu, Takashi Hamazaki, Hsin-Yin Tsai, Kirsten Erger, Thomas Conlon, Ahmed S Elshikha, Hong Li, Arun Srivastava, Chunli Yao, Mark Brantly, Vince Chiodo, William Hauswirth, Naohiro Terada, Sihong Song.   

Abstract

Induced pluripotent stem (iPS) cells have great potential for personalized regenerative medicine. Although several different methods for generating iPS cells have been reported, improvement of safety and efficiency is imperative. In this study, we tested the feasibility of using a triple tyrosine mutant AAV2 (Y444+500+730F) vector, designated AAV2.3m, to generate iPS cells. We developed a polycistronic rAAV2.3m vector expressing three reprogramming factors, Klf4, Oct4, and Sox2, and then used this vector to infect mouse adipose-derived mesenchymal stem cells (AT-MSCs) to induce the generation of iPS cells. We demonstrated that (1) the triple tyrosine mutant AAV2 vector is able to reprogram mouse adult adipose tissue-derived stem cells into the pluripotent state. Those rAAV2.3m-derived iPS (rAAV2.3m-iPS) cells express endogenous pluripotency-associated genes including Oct4, Sox2, and SSEA-1, and form teratomas containing multiple tissues in vivo; (2) c-myc, an oncogene, is dispensable in rAAV2.3m-mediated cellular reprogramming; and (3) transgene expression is undetectable after reprogramming, whereas vector DNA is detectable, indicating that transgenes are silenced. These results indicated the rAAV vector may have some advantages in generating iPS cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24191859      PMCID: PMC3904654          DOI: 10.1089/hgtb.2013.011

Source DB:  PubMed          Journal:  Hum Gene Ther Methods        ISSN: 1946-6536            Impact factor:   2.396


  54 in total

1.  Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors.

Authors:  S Song; J Embury; P J Laipis; K I Berns; J M Crawford; T R Flotte
Journal:  Gene Ther       Date:  2001-09       Impact factor: 5.250

2.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

Review 3.  Integration of adeno-associated virus (AAV) and recombinant AAV vectors.

Authors:  Douglas M McCarty; Samuel M Young; R Jude Samulski
Journal:  Annu Rev Genet       Date:  2004       Impact factor: 16.830

4.  A nonviral minicircle vector for deriving human iPS cells.

Authors:  Fangjun Jia; Kitchener D Wilson; Ning Sun; Deepak M Gupta; Mei Huang; Zongjin Li; Nicholas J Panetta; Zhi Ying Chen; Robert C Robbins; Mark A Kay; Michael T Longaker; Joseph C Wu
Journal:  Nat Methods       Date:  2010-02-07       Impact factor: 28.547

5.  Characterization of a bipartite recombinant adeno-associated viral vector for site-specific integration.

Authors:  C Zhang; N G Cortez; K I Berns
Journal:  Hum Gene Ther       Date:  2007-09       Impact factor: 5.695

6.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

7.  Generation of germline-competent induced pluripotent stem cells.

Authors:  Keisuke Okita; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

8.  Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response.

Authors:  Catherine S Manno; Glenn F Pierce; Valder R Arruda; Bertil Glader; Margaret Ragni; John J Rasko; John Rasko; Margareth C Ozelo; Keith Hoots; Philip Blatt; Barbara Konkle; Michael Dake; Robin Kaye; Mahmood Razavi; Albert Zajko; James Zehnder; Pradip K Rustagi; Hiroyuki Nakai; Amy Chew; Debra Leonard; J Fraser Wright; Ruth R Lessard; Jürg M Sommer; Michael Tigges; Denise Sabatino; Alvin Luk; Haiyan Jiang; Federico Mingozzi; Linda Couto; Hildegund C Ertl; Katherine A High; Mark A Kay
Journal:  Nat Med       Date:  2006-02-12       Impact factor: 53.440

9.  Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.

Authors:  Masato Nakagawa; Michiyo Koyanagi; Koji Tanabe; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Keisuke Okita; Yuji Mochiduki; Nanako Takizawa; Shinya Yamanaka
Journal:  Nat Biotechnol       Date:  2007-11-30       Impact factor: 54.908

10.  Transgenes delivered by lentiviral vector are suppressed in human embryonic stem cells in a promoter-dependent manner.

Authors:  Xiaofeng Xia; Yingsha Zhang; Caroline R Zieth; Su-Chun Zhang
Journal:  Stem Cells Dev       Date:  2007-02       Impact factor: 3.272

View more
  6 in total

1.  Pluripotent stem cells to hepatocytes, the journey so far.

Authors:  Anwar A Palakkan; Jyoti Nanda; James A Ross
Journal:  Biomed Rep       Date:  2017-03-01

2.  Direct conversion of fibroblasts traces the way back to our first organ-the placenta.

Authors:  Elke Winterhager
Journal:  Stem Cell Investig       Date:  2016-09-19

Review 3.  Adipose-Derived Mesenchymal Stromal Cells in Regenerative Medicine: State of Play, Current Clinical Trials, and Future Prospects.

Authors:  Jérôme Laloze; Loïc Fiévet; Alexis Desmoulière
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-06-02       Impact factor: 4.730

4.  In Situ Transplantation of Alginate Bioencapsulated Adipose Tissues Derived Stem Cells (ADSCs) via Hepatic Injection in a Mouse Model.

Authors:  Mong-Jen Chen; Yuanqing Lu; Nicholas E Simpson; Mark J Beveridge; Ahmed S Elshikha; Mohammad Ahsanul Akbar; Hsin-Yin Tsai; Stephanie Hinske; Junling Qin; Christian R Grunwitz; Tina Chen; Mark L Brantly; Sihong Song
Journal:  PLoS One       Date:  2015-09-15       Impact factor: 3.240

5.  AAVvector-mediated in vivo reprogramming into pluripotency.

Authors:  Elena Senís; Lluc Mosteiro; Stefan Wilkening; Ellen Wiedtke; Ali Nowrouzi; Saira Afzal; Raffaele Fronza; Henrik Landerer; Maria Abad; Dominik Niopek; Manfred Schmidt; Manuel Serrano; Dirk Grimm
Journal:  Nat Commun       Date:  2018-07-09       Impact factor: 14.919

6.  Discovering the Potential of Dental Pulp Stem Cells for Corneal Endothelial Cell Production: A Proof of Concept.

Authors:  Begoña M Bosch; Enrique Salero; Raquel Núñez-Toldrà; Alfonso L Sabater; F J Gil; Roman A Perez
Journal:  Front Bioeng Biotechnol       Date:  2021-01-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.